Salt-induced renal injury in spontaneously hypertensive rats: Effects of nebivolol

American Journal of Nephrology

Volumn 32, Issue 6, 2010, Pages 557-566

  Varagic, Jasmina ^a,b   Ahmad, Sarfaraz ^a,b   Brosnihan, K Bridget ^a,b   Habibi, Javad ^c   Tilmon, Roger D ^c   Sowers, James R ^c   Ferrario, Carlos M ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

1 Receptor antagonism; Hypertension; Kidney; Nitric oxide; Oxidative stress; Salt

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 3 RECEPTOR; ANGIOTENSIN 4 RECEPTOR; ANGIOTENSIN 5 RECEPTOR; ANGIOTENSIN 6 RECEPTOR; ANGIOTENSIN 7 RECEPTOR; ANGIOTENSIN RECEPTOR; NEBIVOLOL; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SODIUM RESTRICTION; SPONTANEOUSLY HYPERTENSIVE RAT; URINARY EXCRETION;

ACUTE KIDNEY INJURY; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BENZOPYRANS; BLOOD PRESSURE; ETHANOLAMINES; MALE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PROTEINURIA; PROTO-ONCOGENE PROTEINS; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; RENAL CIRCULATION; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM CHLORIDE;

EID: 77958614887     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321471     Document Type: Article

References (74)

1. Ahn J, Varagic J, Slama M, Susic D, Frohlich ED: Cardiac structural and functional responses to salt loading in SHR. Am J Physiol Heart Circ Physiol 2004; 287:H767-H772.
2. Matavelli LC, Zhou X, Varagic J, Susic D, Frohlich ED: Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2007; 292:H814-H819.
3. Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI: Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998; 98: 2621-2628.
4. Leenen FH, Yuan B: Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat. J Hypertens 1998; 16: 885-892.
5. Hodge G, Ye VZ, Duggan KA: Dysregulation of angiotensin II synthesis is associated with salt sensitivity in the spontaneous hypertensive rat. Acta Physiol Scand 2002; 174: 209-215.
6. Kreutz R, Fernandez-Alfonso MS, Liu Y, Ganten D, Paul M: Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats. J Mol Med 1995; 73: 243-248.
7. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang GX, Yao L, Hitomi H, Shokoji T, Kiyomoto H, Kimura S, Tamaki T, Kohno M, Abe Y: Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int 2004; 65: 972-981. (Pubitemid 38251073)
8. Stier CT Jr, Chander P, Gutstein WH, Levine S, Itskovitz HD: Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens 1991; 4: 680-687.
9. Varagic J, Ahmad S, Brosnihan KB, Groban L, Chappell MC, Tallant EA, Gallagher PE, Ferrario CM: Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction. Ther Adv Cardiovasc Dis 2010; 4: 17-25.
10. Chen X, Touyz RM, Park JB, Schiffrin EL: Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001; 38: 606-611.
11. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS: Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14: 2775-2782.
12. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T: Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 2007; 50: 877-883.
13. Welch WJ, Mendonca M, Blau J, Karber A, Dennehy K, Patel K, Lao YS, Jose PA, Wilcox CS: Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int 2005; 68: 179-187.
14. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS: Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002; 39: 269-274.
15. Hayden MR, Habibi J, Whaley-Connell A, Sowers D, Johnson M, Tilmon R, Jain D, Ferrario C, Sowers JR: Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats. Am J Nephrol 2010; 31: 262-272.
16. Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, Gallagher PE, Tallant EA, Cooper SA, Link CD, Ferrario C, Sowers JR: Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Am J Physiol Renal Physiol 2006; 291:F1308-F1314.
17. Fujii S, Zhang L, Igarashi J, Kosaka H: L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension 2003; 42: 1014-1020.
18. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A, Corna D, Zoja C, Cavallotti D, Remuzzi G: Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 1997; 52: 171-181.
19. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-281.
20. Nakamura Y, Ono H, Zhou X, Frohlich ED: Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L 1 -arginine methyl ester/spontaneously hypertensive rats. Hypertension 2001; 37: 1262-1267.
21. Vaziri ND, Ding Y, Ni Z, Gonick HC: Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy. Kidney Int 1997; 52: 1042-1046.
22. Vaziri ND, Ni Z, Wang XQ, Oveisi F, Zhou XJ: Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol 1998; 274:F642-F649.
23. Blum M, Yachnin T, Wollman Y, Chernihovsky T, Peer G, Grosskopf I, Kaplan E, Silverberg D, Cabili S, Iaina A: Low nitric oxide production in patients with chronic renal failure. Nephron 1998; 79: 265-268.
24. Schmidt RJ, Yokota S, Tracy TS, Sorkin MI, Baylis C: Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis. Am J Physiol 1999; 276:F794-F797.
25. Majid DS, Navar LG: Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertens 2001; 14: 74S-82S.
26. Raij L, Baylis C: Glomerular actions of nitric oxide. Kidney Int 1995; 48: 20-32.
27. Mattson DL, Higgins DJ: Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 1996; 27: 688-692.
28. Kihara M, Sato K, Hashimoto T, Imai N, Toya Y, Umemura S: Expression of endothelial nitric oxide synthase is suppressed in the renal vasculature of angiotensinogen-gene knockout mice. Cell Tissue Res 2006; 323: 313-320.
29. Hayakawa H, Raij L: Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 1998; 31: 266-270.
30. Ni Z, Vaziri ND: Effect of salt loading on nitric oxide synthase expression in normotensive rats. Am J Hypertens 2001; 14: 155-163.
31. Nishimoto Y, Tomida T, Matsui H, Ito T, Okumura K: Decrease in renal medullary endothelial nitric oxide synthase of fructosefed, salt-sensitive hypertensive rats. Hypertension 2002; 40: 190-194.
32. Singh I, Grams M, Wang WH, Yang T, Killen P, Smart A, Schnermann J, Briggs JP: Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt. Am J Physiol 1996; 270:F1027-F1037.
33. Mason RP, Kalinowski L, Jacob RF, Jacoby AM, Malinski T: Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans. Circulation 2005; 112: 3795-3801.
34. Mason RP, Kubant R, Jacob RF, Walter MF, Boychuk B, Malinski T: Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: role of antioxidant activity. J Cardiovasc Pharmacol 2006; 48: 862-869.
35. Benter IF, Yousif MH, Dhaunsi GS, Kaur J, Chappell MC, Diz DI: Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 2008; 28: 25-33.
36. Gwathmey TM, Pendergrass KD, Reid SD, Rose JC, Diz DI, Chappell MC: Angiotensin- (1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension 2010; 55: 166-171.
37. Pinheiro SV, Ferreira AJ, Kitten GT, da Silveira KD, da Silva DA, Santos SH, Gava E, Castro CH, Magalhaes JA, da Mota RK, Botelho-Santos GA, Bader M, Alenina N, Santos RA, Simoes e Silva AC: Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney Int 2009; 75: 1184-1193.
38. Zhang J, Noble NA, Border WA, Huang Y: Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 2010; 298:F579-F588.
39. Varagic J, Jerkic M, Jovovic D, Nastic-Miric D, Adanja-Grujic G, Markovic-Lipkovski J, Lackovic V, Radujkovic-Kuburovic G, Kentera D: Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats. Am J Med Sci 2000; 320: 171-176.
40. Yamaleyeva LM, Gallagher PE, Vinsant S, Chappell MC: Discoordinate regulation of renal nitric oxide synthase isoforms in ovariectomized mRen2. Lewis rats. Am J Physiol Regul Integr Comp Physiol 2007; 292:R819-R826.
41. Habibi J, Whaley-Connell A, Qazi MA, Hayden MR, Cooper SA, Tramontano A, Thyfault J, Stump C, Ferrario C, Muniyappa R, Sowers JR: Rosuvastatin, a 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats. Endocrinology 2007; 148: 2181-2188.
42. Susic D, Zhou X, Frohlich ED, Lippton H, Knight M: Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet. Am J Physiol Heart Circ Physiol 2008; 295:H1117-H1121.
43. Susic D, Zhou X, Frohlich ED: Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats. Am J Nephrol 2009; 29: 639-645.
44. Cosentino F, Bonetti S, Rehorik R, Eto M, Werner-Felmayer G, Volpe M, Luscher TF: Nitric-oxide-mediated relaxations in saltinduced hypertension: effect of chronic beta1 -selective receptor blockade. J Hypertens 2002; 20: 421-428.
45. Varagic J, Frohlich ED, Susic D, Ahn J, Matavelli L, Lopez B, Diez J: AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure. Am J Physiol Heart Circ Physiol 2008; 294:H853-H858.
46. Alenina N, Xu P, Rentzsch B, Patkin EL, Bader M: Genetically altered animal models for Mas and angiotensin-(1-7). Exp Physiol 2008; 93: 528-537.
47. Su Z, Zimpelmann J, Burns KD: Angiotensin-( 1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006; 69: 2212-2218.
48. Ren Y, Garvin JL, Carretero OA: Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 2002; 39: 799-802.
49. Dharmani M, Mustafa MR, Achike FI, Sim MK: Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin- induced diabetic rats. Eur J Pharmacol 2007; 561: 144-150.
50. Botelho-Santos GA, Sampaio WO, Reudelhuber TL, Bader M, Campagnole-Santos MJ, Souza dos Santos RA: Expression of an angiotensin-( 1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance. Am J Physiol Heart Circ Physiol 2007; 292:H2485-H2490.
51. Sampaio WO, Nascimento AA, Santos RA: Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am J Physiol Heart Circ Physiol 2003; 284:H1985-H1994.
52. Barki-Harrington L, Luttrell LM, Rockman HA: Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 2003; 108: 1611-1618.
53. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response. J Clin Invest 1994; 93: 311-320.
54. DeRubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 1994; 43: 1-8.
55. Tian N, Moore RS, Phillips WE, Lin L, Braddy S, Pryor JS, Stockstill RL, Hughson MD, Manning RD Jr: NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 2008; 295:R1858-R1865.
56. Touyz RM: Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44: 248-252.
57. Chandramohan G, Bai Y, Norris K, Rodriguez- Iturbe B, Vaziri ND: Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI- 1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Am J Nephrol 2008; 28: 158-167.
58. Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-456.
59. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL, Myatt L: Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 1998; 21: 1753-1758.
60. Thuraisingham RC, Nott CA, Dodd SM, Yaqoob MM: Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int 2000; 57: 1968-1972.
61. Vaziri ND, Wang XQ: cGMP-mediated negative- feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension 1999; 34: 1237-1241.
62. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL: Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 2000; 36: 957-964.
63. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003; 111: 1201-1209.
64. Troost R, Schwedhelm E, Rojczyk S, Tsikas D, Frolich JC: Nebivolol decreases systemic oxidative stress in healthy volunteers. Br J Clin Pharmacol 2000; 50: 377-379.
65. Georgescu A, Pluteanu F, Flonta ML, Badila E, Dorobantu M, Popov D: The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery. Eur J Pharmacol 2005; 508: 159-166.
66. Pires MJ, Rodriguez-Pena AB, Arevalo M, Cenador B, Evangelista S, Esteller A, Sanchez- Rodriguez A, Colaco A, Lopez-Novoa JM: Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction. J Hypertens 2007; 25: 2486-2496.
67. Toprak O, Cirit M, Tanrisev M, Yazici C, Canoz O, Sipahioglu M, Uzum A, Ersoy R, Sozmen EY: Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant 2008; 23: 853-859.
68. Gill PS, Wilcox CS: NADPH oxidases in the kidney. Antioxid Redox Signal 2006; 8: 1597-1607.
69. Bachmann S, Bosse HM, Mundel P: Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol 1995; 268:F885-F898.
70. Bennai F, Morsing P, Paliege A, Ketteler M, Mayer B, Tapp R, Bachmann S: Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats. J Am Soc Nephrol 1999;(suppl 11):S104-S115.
71. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, Mayer B, Kriz W: Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 1992; 42: 1017-1019.
72. Tojo A, Onozato ML, Fukuda S, Asaba K, Kimura K, Fujita T: Nitric oxide generated by nNOS in the macula densa regulates the afferent arteriolar diameter in rat kidney. Med Electron Microsc 2004; 37: 236-241.
73. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HH: Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 1992; 89: 11993-11997.
74. Moens AL, Yang R, Watts VL, Barouch LA: Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system. J Mol Cell Cardiol 2010; 48: 1088-1095.